Laura Soucek raises her first million!

PEPTOMYC, the spin off led by Laura Soucek (ICREA at VHIO) has just raised 1 million to complete preclinical developent of a novel tumor inhibitor, a peptyde that blocks the MYC gene, which sits in the centrer of all the signalling cascade that leads to tumor groth and proliferation. Blocking MYC has proved very successful in preclical trials: tumors seem unable to find a way around MYC, and recede very dramatically.

We wish them best of luck and we hope to see the therapy in use some time, sooner rather than later!